CVB.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 24, 2025
Report Source: 2024 Annual Report
Curvebeam AI Ltd. Stock Analysis CVB.AX
CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Its products include HiRise, LineUp, PedCAT Premium, pedCAT, InReach, OssView, CubeVue Software, Autometrics, 3D Measurement Tools and Cloud. HiRise is a bilateral, weight-bearing CT imaging of the entire lower extremities including hips/pelvis and distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach is a point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities. InReach HR-pQCT is a high-resolution peripheral quantitative CT (HR-pQCT) imaging designed for the point-of-care. OssView is a bone fragility software that analyzes HR-pQCT images at the distal radius to measure the bone microarchitecture.
Read More Curvebeam AI Ltd (CVB.AX) Chart
Key Statistics of Curvebeam AI Ltd (CVB.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.05Volume
12.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
28.19MAvg. Volume
118.52KDividend Yield
-Financial Metrics & Statements of Curvebeam AI Ltd (CVB.AX)
FAQ's for Curvebeam AI Ltd (CVB.AX)
- According to Musaffa’s Shariah screening methodology, Curvebeam AI Ltd (CVB.AX) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.